CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net (loss) income	$ (3,161)	$ 9,543	$ (17,084)
(Income) loss from discontinued operations	(1,170)	10,109	15,227
(Loss) income from continuing operations	(4,331)	19,652	(1,857)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	195	126	222
Gain on settlement of pre-petition liabilities	(26)	(1,331)	0
Gain on sale of certain assets	0	(17,714)	0
Loss on disposal of property and equipment	0	164	0
Provision (recovery) for doubtful accounts	6	7	(93)
Share-based compensation	105	21	32
Loss on sale of investment securities	0	0	910
Changes in operating assets and liabilities:
Inventories	(137)	0	0
Accounts receivable	200	1,742	(296)
Income taxes receivable	0	0	26
Prepaid expenses and other current assets	(187)	851	(150)
Other assets - net	99	(84)	7
Due to licensors	(130)	(546)	(704)
Accounts payable and accrued expenses	(3,051)	1,302	2,082
Liabilities subject to compromise	(932)	(5,218)	7,507
Deferred revenue	(2)	(2)	(1,035)
Deferred rent	23	0	0
Net cash (used in) provided by continuing operating activities	(8,168)	(1,030)	6,651
Net cash used in discontinued operating activities	(148)	(5,602)	(15,485)
Net cash used in operating activities	(8,316)	(6,632)	(8,834)
Cash flows from investing activities:
Proceeds from sale of investments	0	0	6,216
Proceeds from sale of certain assets	1,000	13,997	0
Acquisition of assets	(2,100)	0	0
Purchase of property and equipment	(26)	0	(2)
Proceeds from disposal of property and equipment	0	0	25
Net cash (used in) provided by investing activities	(1,126)	13,997	6,239
Cash flows from financing activities:
Capital contribution from noncontrolling interests	787	0	0
Net cash provided by financing activities	787	0	0
Effects of exchange rate changes on cash and cash equivalents	0	19	27
Net (decrease) increase in cash and cash equivalents	(8,655)	7,384	(2,568)
Cash and cash equivalents, beginning of period	9,011	1,627	4,195
Cash and cash equivalents, end of period	356	9,011	1,627
Supplemental schedule of non-cash investing and financing activities
Vesting of restricted shares	0	88	738
In conjunction with the sale of certain of the Company's assets pursuant to the Asset Purchase Agreement
Other assets - continuing, acquired by buyers	0	1,596	0
Film costs, accounts receivable, other assets - discontinued, acquired by buyers	0	2,329	0
Accounts payable and accrued expenses-discontinued, assumed by buyers	$ 0	$ 6,642	$ 0